Evidence map›Paper›PMID 34866320›Full record

ArticleEMBO reports2022

Tet enzymes are essential for early embryogenesis and completion of embryonic genome activation.

Julia Arand, H Rosaria Chiang, David Martin, Michael P Snyder, Julien Sage, Renee A Reijo Pera, Mark Wossidlo

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Epigenetic remodeling during early embryonic development.Frontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Epigenetic Consequences of In Utero PFAS Exposure: Implications for Development and Long-Term Health.International journal of environmental research and public health · 2025
    Review
  8. Article
  9. The Mammalian Oocyte: A Central Hub for Cellular Reprogramming and Stemness.Stem cells and cloning : advances and applications · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. PADI6: What we know about the elusive fifth member of the peptidyl arginine deiminase family.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Julia ArandCenter of Anatomy and Cell Biology, Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-2357-1119
H Rosaria ChiangInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
David MartinCenter of Anatomy and Cell Biology, Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria.
Michael P SnyderDepartment of Genetics, Stanford University, Stanford, CA, USA.ORCID 0000-0003-0784-7987
Julien SageInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8928-9968
Renee A Reijo PeraInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
Mark WossidloCenter of Anatomy and Cell Biology, Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-3184-0753
California Institute for Regenerative Medicine · USMedical University of Vienna · ATStanford University · US

Funding

Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
Molecular basis of tumor suppression by Cdk4/6 inhibitionR01CA228413 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI RUBIN, SETH MICHAEL, SAGE, JULIEN · 2019 to 2023
$1.8M
Dissection of the transcriptional network of human primordial germ cellsR01HD096026 · NICHD · MONTANA STATE UNIVERSITY - BOZEMAN · PI REIJO PERA, RENEE A · 2018 to 2022
$1.6M
NCI NIH HHS R01 CA228413NCI NIH HHS T32 CA009302NHLBI NIH HHS U01 HL100397NICHD NIH HHS R01 HD096026
6 · The paper itself

Abstract

Mammalian development begins in transcriptional silence followed by a period of widespread activation of thousands of genes. DNA methylation reprogramming is integral to embryogenesis and linked to Tet enzymes, but their function in early development is not well understood. Here, we generate combined deficiencies of all three Tet enzymes in mouse oocytes using a morpholino-guided knockdown approach and study the impact of acute Tet enzyme deficiencies on preimplantation development. Tet1-3 deficient embryos arrest at the 2-cell stage with the most severe phenotype linked to Tet2. Individual Tet enzymes display non-redundant roles in the consecutive oxidation of 5-methylcytosine to 5-carboxylcytosine. Gene expression analysis uncovers that Tet enzymes are required for completion of embryonic genome activation (EGA) and fine-tuned expression of transposable elements and chimeric transcripts. Whole-genome bisulfite sequencing reveals minor changes of global DNA methylation in Tet-deficient 2-cell embryos, suggesting an important role of non-catalytic functions of Tet enzymes in early embryogenesis. Our results demonstrate that Tet enzymes are key components of the clock that regulates the timing and extent of EGA in mammalian embryos.

Indexed as

Dioxygenases5-MethylcytosineAnimalsDNA MethylationEmbryo, MammalianEmbryonic DevelopmentMice5-MethylcytosineDioxygenasesDNA methylation reprogrammingembryonic genome activationTet enzymestotipotencytransposable elements

Identifiers

PMID34866320
PMCPMC8811641
OpenAlexW4200469338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.